Maresyl 0,5 Mg/Ml (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts as a selective alpha‑adrenergic agonist. By stimulating α‑adrenergic receptors on the blood vessels of the nasal mucosa, it induces vasoconstriction, which decreases blood flow, reduces edema, and opens the nasal passages, providing rapid relief from congestion.

The appropriate dose of Maresyl 0,5 Mg/mL is determined by the prescribing clinician based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but exact instructions should be obtained from a qualified healthcare provider and followed on the product label.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Maresyl. The prescriber will weigh potential benefits against any possible risks to mother and infant.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maresyl’s active ingredient, Xylometazoline, belongs to the imidazoline class, which provides rapid vasoconstriction with a relatively low incidence of systemic side effects compared with phenylephrine‑based sprays. It offers similar efficacy to oxymetazoline but may have a slightly longer duration of action, making it a common alternative for short‑term relief.

Maresyl should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect the bottle from moisture, direct sunlight, and extreme temperature fluctuations. Ensure the cap is tightly closed to maintain product stability throughout its shelf life.

Maresyl is a nasal solution intended for intranasal administration. The user tilts the head slightly forward, inserts the nozzle into a nostril, and sprays the prescribed number of actuations. The spray should be directed away from the nasal septum to minimize irritation, and the recommended dose should not be exceeded.

The most serious adverse reactions include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, hypertension, and, rarely, cardiac arrhythmias. Patients experiencing persistent nasal blockage, elevated blood pressure, or irregular heartbeats should discontinue use and seek medical attention promptly.

Maresyl is contraindicated in individuals with known hypersensitivity to Xylometazoline Hydrochloride or any other component of the formulation. It should also be avoided in children under the age recommended by the label, typically under six years, and in patients with severe hypertension or certain cardiovascular disorders unless directed by a physician.